Photo of Winn, Robert A.

Robert A. Winn, MD

Associate Vice Chancellor for Community Based Practice

Director, University of Illinois Cancer Center, Professor of Medicine, Clinical Professor of Surgery

Email:

rwinn@uic.edu

About

Dr. Robert A. Winn is an accomplished physician-scientist and a proponent of the “bench to community” model of research. He is committed to developing methods to ensure equal access to cutting-edge medical treatments and eliminate health disparities in Illinois and beyond.

As the Associate Vice Chancellor for Community-Based Practice, Dr. Winn oversees management of the UI Health Mile Square Health Center, a 13-site Federally Qualified Health Center (FQHC) network.   His vision for Mile Square is to build a 21st Century model of community-based health care providers that reflects the mission of the academic health center and develops meaningful research programs that, if adopted, can enhance the overall well-being of the community.

As Director of the UI Cancer Center, Dr. Winn works tirelessly to bridge the gap between basic science and community-based health care.  He is a principal investigator on several community-based NIH- and NCI-funded projects including U54 ChicagoCHEC, U54 Cher Chicago, the  P20 GUIDE Project, and the UG3 All of Us Precision Medicine Initiative.

Dr. Winn’s basic science research, which has been supported by multiple NIH and VA Merit awards, focuses on the translational aspects of the role the proliferation pathways and cellular senescence play in lung cancer. He has received national and international acclaim for his efforts to empower underserved patient populations, improve health care delivery, and ensure equal access to cutting-edge medical treatments.

Dr. Winn received his medical degree from the University of Michigan Medical School in Ann Arbor. He completed his medical residency at Rush Presbyterian St. Luke’s Medical Center in Chicago, and a Pulmonary/Critical Care Medicine fellowship at the University of Colorado School of Medicine. He is a member of the National Cancer Policy Forum of the National Academies of Sciences, Engineering, and Medicine.